<DOC>
	<DOCNO>NCT03067194</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety Celecoxib capsule hand osteoarthritis patient .</brief_summary>
	<brief_title>The Study Evaluate Efficacy Safety Celecoxib Capsule Hand Osteoarthritis Patients</brief_title>
	<detailed_description>This six-weeks , open-label , multi-center , randomize study . Patients take Celecoxib 200mg capsule day Celecoxib 100mg capsule twice per day . If patient tolerate pain , able take Acetaminophen rescue medication 6 week .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<criteria>Agreement write informed consent 19 year age old Patients history OA hand accord ACR criteria The 100mm Pain VAS 40mm History OA hand surgery Intraarticular injection within 3 month History OA hand infection within 3 month Who take drug control result clinical trial investigator 's decision Pregnant woman , nurse mother Fertile woman practice contraception appropriate method clinically significant hepatic , renal , cardiovascular disease Any history adverse reaction study drug Patients gastrointestinal ulcer bleed disorder Finger joint injury within 6 month Who follow result examination 1 . K ≥ 5.5mEq/L 2. eGFR ≤ 30ml/min/1.73m^2 Patients clinical trial experimental treatment past 3 month Taking narcotic analgesic patch History drug abuse alcoholism Who Galactose intolerance , LAPP lactose intolerance , glucosegalactose malabsorption genetic disorder An impossible one participate clinical trial investigator 's decision</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Osteoarthritis Hand</keyword>
</DOC>